TJX Companies
TJX
$124.60
-1.10%
TJX Companies is the world's largest off-price apparel and home fashions retailer, operating more than 5,000 stores across nine countries through four segments — Marmaxx (61% of sales), HomeGoods (17%), TJX Canada (9%), and TJX International (13%) — with roughly $60 billion in annual sales. Its competitive identity rests on a scaled, high-turnover off-price model that buys branded merchandise at deep discounts and sells it at 20-60% below full-price retail, a structural advantage that has historically delivered consistent traffic and defensive performance through consumer cycles. The current investor narrative has turned sharply negative: despite a Q1 FY2027 beat (revenue +9.2% YoY to $14.32 billion, EPS $1.19), the stock fell roughly 15% in August after full-year profit guidance missed expectations and two analysts downgraded the name, with valuation and decelerating comparable-store growth (4% versus Ross Stores' 10%) now the central debate. The stock has lost 10.5% over the past year and 18.3% year-to-date, dramatically underperforming a SPY that gained 16.2% over the same twelve months, as investors question whether the off-price growth premium is still warranted.…
TJX
TJX Companies
$124.60
Related headlines
Investment Opinion: Should I buy TJX Today?
Rating: Hold. The core thesis is that TJX is a high-quality off-price retailer with a resilient business model and strong cash flow, but its premium valuation and decelerating comparable sales growth create an unfavorable risk/reward at current levels. The analyst consensus rating of 'buy' with an average target of $169.80 implies 34.7% upside, but the recent guidance miss and two downgrades suggest that target may be stale and needs to be revised lower.
Supporting evidence for a Hold includes: (1) forward PE of 21.8x is a discount to trailing 30.6x, but still above the retail sector median of roughly 18x; (2) revenue grew 9.2% year-over-year in Q1 FY2027, but comparable sales growth of 4% lags Ross Stores' 10%; (3) net margin of 9.1% and operating margin of 11.9% are solid but trending downward from 13.3% operating margin in Q4 FY2026; (4) free cash flow of $5.48 billion is robust, supporting a 1.09% dividend yield and buybacks; and (5) the stock trades at a 16.5x price-to-book, which is historically high for a retailer with a 53.9% ROE but may not be sustainable if growth slows.
The biggest risks that could invalidate the Hold rating are: (1) a further decline in comparable sales growth below 4%, which would likely trigger additional downgrades and multiple compression; (2) continued margin erosion if cost pressures persist, potentially pushing operating margin below 11%; and (3) a broader consumer slowdown that disproportionately affects discretionary retail. The rating would upgrade to Buy if the stock falls below $115 (implying a forward PE below 17x) or if comparable sales growth reaccelerates above 6% for two consecutive quarters. It would downgrade to Sell if comparable sales growth turns negative or if operating margin falls below 10%. Relative to its own history and peers, TJX appears overvalued on trailing metrics but fairly valued on forward earnings, suggesting the market is pricing in a recovery that has yet to be proven.
Sign up to view all
TJX 12-Month Price Forecast
TJX presents a balanced risk/reward at current levels. The stock has fallen 25% over three months and trades just above its 52-week low, which may attract value investors, but the deceleration in comparable sales growth and premium valuation relative to peers are significant concerns. The low beta of 0.593 and strong cash flow make it a defensive holding, but the lack of near-term catalysts and the risk of further guidance cuts keep us neutral. We would upgrade to bullish if comparable sales growth reaccelerates above 6% or if the stock drops below $115, and downgrade to bearish if comparable sales growth turns negative or operating margin falls below 10%.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on TJX Companies's 12-month outlook, with a consensus price target around $169.80 and implied upside of +36.3% versus the current price.
Average Target
$169.80
0 analysts
Implied Upside
+36.3%
vs. current price
Analyst Count
—
covering this stock
Price Range
$136 - $198
Analyst target range
Bulls vs Bears: TJX Investment Factors
The bear case currently has stronger evidence: TJX is down 25% over three months, comparable sales growth of 4% badly trails Ross Stores' 10%, and the stock trades at a premium 30.6x trailing PE despite decelerating momentum. However, the bull case rests on deep value—forward PE of 21.8x, 34.7% upside to analyst targets, and a resilient off-price model that could shine if the economy weakens. The single most important tension is whether TJX's comparable sales growth can reaccelerate toward mid-single digits or better; if it does, the stock is materially undervalued, but if it stalls near 4%, the premium multiple will likely compress further. The market is currently pricing in the latter scenario, but the analyst consensus and low beta suggest a balanced risk/reward for patient investors.
Bullish
- Deep Value After 25% Drawdown: TJX has fallen 25.2% over the past three months and trades at $126.02, just 0.9% above its 52-week low of $124.87. The forward PE of 21.8x is a meaningful discount to the trailing PE of 30.6x, implying the market is pricing in an earnings recovery that has yet to be reflected in the share price.
- Analyst Targets Imply 35% Upside: The average analyst target price is $169.80, representing 34.7% upside from the current price, with a high target of $198.00 (57.1% upside). The consensus recommendation is 'buy' with a mean rating of 1.59 out of 5, indicating that despite recent downgrades, the majority of the 20 covering analysts remain constructive.
- Off-Price Model Proves Resilient: Q1 FY2027 revenue grew 9.2% year-over-year to $14.32 billion, beating expectations, and EPS of $1.19 exceeded estimates. The off-price model's ability to buy branded merchandise at deep discounts and sell 20-60% below full-price retail provides a structural traffic advantage that has historically performed well during consumer downturns.
- Strong Cash Generation and Balance Sheet: TJX generated $5.48 billion in trailing free cash flow and carries a current ratio of 1.14, indicating ample liquidity. The debt-to-equity ratio of 1.32 is manageable for a retailer with consistent profitability, and the 1.09% dividend yield is backed by a conservative 33.5% payout ratio.
Bearish
- Comparable Sales Growth Lags Ross Stores: TJX reported 4% comparable-store sales growth in its most recent quarter, while competitor Ross Stores grew comparable sales 10% and raised guidance. This stark divergence suggests TJX is losing market share in the off-price segment, undermining its historical growth premium.
- Guidance Miss Triggered Sharp Selloff: Despite beating Q1 earnings, TJX's stock fell 15% in August after full-year profit guidance missed analyst expectations, leading to two analyst downgrades. The market's harsh reaction highlights how sensitive the stock is to any sign of margin or earnings deceleration.
- Premium Valuation Not Justified by Growth: The trailing PE of 30.6x and price-to-book of 16.5x are rich for a retailer with a 9.1% net margin and 9.2% revenue growth. The PEG ratio of 2.28 suggests the market is paying a significant premium for growth that may not materialize if comparable sales remain sluggish.
- Margin Pressure from Rising Costs: Gross margin in Q1 FY2027 was 31.3%, down from 32.9% in Q3 FY2026, and operating margin of 11.9% is below the 13.3% reported in Q4 FY2026. If input costs and wage pressures persist, further margin erosion could compress earnings and justify a lower multiple.
TJX Technical Analysis
Beta
0.59
0.59x market volatility
Max Drawdown
-26.0%
Largest decline past year
52-Week Range
$124-$170
Price range past year
Annual Return
-11.7%
Cumulative gain past year
| Period | TJX Return | S&P 500 |
|---|---|---|
| 1m | -18.1% | -2.4% |
| 3m | -24.1% | +2.2% |
| 6m | -19.4% | +14.8% |
| 1y | -11.7% | +14.6% |
| ytd | -19.2% | +11.1% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
TJX Fundamental Analysis
Quarterly Revenue
$14.3B
2026-05
Revenue YoY Growth
+9.2%
YoY Comparison
Gross Margin
31.3%
Latest Quarter
Free Cash Flow
$5.5B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is TJX Overvalued?
PE
30.6x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 19x~35x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
20.6x
Enterprise Value Multiple
Investment Risk Disclosure
TJX faces financial risks primarily from margin compression and a premium valuation that leaves little room for error. Gross margin declined to 31.3% in Q1 FY2027 from 32.9% in Q3 FY2026, and operating margin fell to 11.9% from 13.3% over the same period, indicating cost pressures are eroding profitability. The debt-to-equity ratio of 1.32 is elevated for a retailer, though interest coverage remains comfortable with $1.69 billion in quarterly operating income against just $18 million in interest expense. The company's $5.48 billion in trailing free cash flow provides a cushion, but any further margin deterioration could threaten the dividend and share buyback capacity.
Market and competitive risks are intensifying as Ross Stores accelerates comparable sales growth to 10% while TJX manages only 4%, signaling potential market share loss in the off-price segment. The stock's beta of 0.593 offers some defensiveness, but TJX has still underperformed SPY by 26.7% over the past year, and the recent 15% single-day drop on guidance shows how quickly sentiment can turn. Valuation risk is acute: the trailing PE of 30.6x and price-to-book of 16.5x are well above historical norms for a retailer with 9.1% net margins, and the PEG ratio of 2.28 suggests the market is pricing in growth that may not materialize. Additionally, Fed Chair Kevin Warsh's 'no tolerance' stance on inflation raises the risk of future rate hikes, which could further compress consumer discretionary multiples.
The worst-case scenario involves a continued deceleration in comparable sales, further margin erosion, and a broader consumer slowdown that forces TJX to guide down again. In this scenario, the stock could retest its 52-week low of $124.87, representing a 0.9% decline from the current price of $126.02, but if the low is breached, the next support could be the analyst low target of $136.00—though that is above the current price, indicating the stock is already trading below the most bearish analyst target. A more severe outcome would see the stock fall to the $110-$115 range, a 9-13% decline from current levels, if earnings estimates are cut and the multiple compresses to 18x forward earnings. From the current price, investors could lose 10-15% in a realistic bear case, with the 52-week low at $124.87 serving as the first line of defense.
FAQ
The key risks for TJX are ranked as follows: (1) Competitive risk: Ross Stores' 10% comparable sales growth versus TJX's 4% indicates market share loss, which could pressure future growth. (2) Valuation risk: the trailing PE of 30.6x and PEG of 2.28 leave little room for error; any earnings miss could trigger a sharp selloff. (3) Margin risk: gross margin fell to 31.3% in Q1 FY2027 from 32.9% in Q3 FY2026, and further erosion could compress earnings. (4) Macro risk: with a beta of 0.593, TJX is defensive, but a consumer slowdown could still hurt discretionary spending. The most severe risk is a combination of these factors leading to a break below the 52-week low of $124.87.
Our 12-month forecast for TJX includes three scenarios: a base case (55% probability) with a target range of $140-$170, assuming comparable sales growth stabilizes at 4-5% and EPS meets the $6.85 consensus; a bull case (25% probability) targeting $170-$198, driven by reaccelerating comparable sales growth above 6% and margin expansion; and a bear case (20% probability) targeting $110-$136, if comparable sales growth decelerates to 2% or lower and margins compress further. The most likely scenario is the base case, which implies a return to the analyst average target of $169.80 over time. The key assumption is that TJX can maintain at least 4% comparable sales growth and hold operating margin above 11.5%.
TJX appears fairly valued on forward earnings but overvalued on trailing metrics. The trailing PE of 30.6x and price-to-book of 16.5x are well above the retail sector median, while the forward PE of 21.8x is more reasonable but still above the sector average of roughly 18x. The PEG ratio of 2.28 suggests the market is paying a premium for growth that may not materialize. Compared to its own history, TJX typically traded at a forward PE of 18-20x, so the current multiple implies the market expects a recovery. If growth disappoints, the stock could see further multiple compression toward 18x, implying a price near $123.
TJX is a good buy for value-oriented investors with a long-term horizon, but it carries above-average near-term risk. The stock trades at $126.02, just 0.9% above its 52-week low, and offers 34.7% upside to the analyst average target of $169.80. However, comparable sales growth of 4% lags Ross Stores' 10%, and the forward PE of 21.8x is not cheap relative to peers. The biggest downside risk is a break below the 52-week low, which could lead to a 10-15% decline. For patient investors, the risk/reward is favorable, but those seeking near-term gains may find better opportunities elsewhere.
TJX is more suitable for long-term investment than short-term trading. The company operates in a stable, defensive industry with a beta of 0.593, and its off-price model has historically performed well through economic cycles. The dividend yield of 1.09% and consistent free cash flow of $5.48 billion make it an attractive holding for income and growth. However, the stock is currently in a downtrend, with a 25.2% decline over three months, so short-term traders may find better opportunities. We recommend a minimum holding period of 2-3 years to allow for a full recovery in comparable sales growth and valuation multiple. Near-term volatility is likely, but the long-term risk/reward is favorable for patient investors.